These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 12163125)

  • 1. Rational identification of new antibacterial drug targets that are essential for viability using a genomics-based approach.
    Chalker AF; Lunsford RD
    Pharmacol Ther; 2002 Jul; 95(1):1-20. PubMed ID: 12163125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of genomics in antibacterial target discovery.
    Buysse JM
    Curr Med Chem; 2001 Dec; 8(14):1713-26. PubMed ID: 11562290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomics and the prospects for the discovery of new targets for antibacterial and antifungal agents.
    Isaacson RE
    Curr Pharm Des; 2002; 8(13):1091-8. PubMed ID: 12052221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomics in anti-infective drug discovery--getting to endgame.
    Haney SA; Alksne LE; Dunman PM; Murphy E; Projan SJ
    Curr Pharm Des; 2002; 8(13):1099-118. PubMed ID: 12052222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targets and assays for discovering novel antibacterial agents.
    Donadio S; Carrano L; Brandi L; Serina S; Soffientini A; Raimondi E; Montanini N; Sosio M; Gualerzi CO
    J Biotechnol; 2002 Nov; 99(3):175-85. PubMed ID: 12385707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microbial genomics and novel antibiotic discovery: new technology to search for new drugs.
    Dougherty TJ; Barrett JF; Pucci MJ
    Curr Pharm Des; 2002; 8(13):1119-35. PubMed ID: 12052223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T-iDT : tool for identification of drug target in bacteria and validation by Mycobacterium tuberculosis.
    Singh NK; Selvam SM; Chakravarthy P
    In Silico Biol; 2006; 6(6):485-93. PubMed ID: 17518759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of genomics to select antibacterial targets.
    Pucci MJ
    Biochem Pharmacol; 2006 Mar; 71(7):1066-72. PubMed ID: 16412986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Streptococcus pneumoniae as a genomics platform for broad-spectrum antibiotic discovery.
    Glass JI; Belanger AE; Robertson GT
    Curr Opin Microbiol; 2002 Jun; 5(3):338-42. PubMed ID: 12057692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using genomics to develop novel antibacterial therapeutics.
    Nagaraj NS; Singh OV
    Crit Rev Microbiol; 2010 Nov; 36(4):340-8. PubMed ID: 20670176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel antibacterials: a genomics approach to drug discovery.
    Chan PF; Macarron R; Payne DJ; Zalacain M; Holmes DJ
    Curr Drug Targets Infect Disord; 2002 Dec; 2(4):291-308. PubMed ID: 12570737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptide ligands in antibacterial drug discovery: use as inhibitors in target validation and target-based screening.
    Lapan KA; Chapple JP; Galcheva-Gargova Z; Yang M; Tao J
    Expert Opin Ther Targets; 2002 Aug; 6(4):507-16. PubMed ID: 12223065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel genetic techniques and approaches in the microbial genomics era: identification and/or validation of targets for the discovery of new antibacterial agents.
    Pucci MJ
    Drugs R D; 2007; 8(4):201-12. PubMed ID: 17596107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibacterial drug discovery--then, now and the genomics future.
    Monaghan RL; Barrett JF
    Biochem Pharmacol; 2006 Mar; 71(7):901-9. PubMed ID: 16494849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional genomics in antibacterial drug discovery.
    Freiberg C; Brötz-Oesterhelt H
    Drug Discov Today; 2005 Jul; 10(13):927-35. PubMed ID: 15993812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic strategies for antibacterial drug discovery.
    Miesel L; Greene J; Black TA
    Nat Rev Genet; 2003 Jun; 4(6):442-56. PubMed ID: 12776214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microbial genomics and drug discovery: exploring innovative routes of drug discovery in the postgenomic era.
    Dougherty TJ; Miller PF
    IDrugs; 2006 Jun; 9(6):420-2. PubMed ID: 16752312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural genomics of highly conserved microbial genes of unknown function in search of new antibacterial targets.
    Abergel C; Coutard B; Byrne D; Chenivesse S; Claude JB; Deregnaucourt C; Fricaux T; Gianesini-Boutreux C; Jeudy S; Lebrun R; Maza C; Notredame C; Poirot O; Suhre K; Varagnol M; Claverie JM
    J Struct Funct Genomics; 2003; 4(2-3):141-57. PubMed ID: 14649299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of genomics in the discovery of novel targets for antibiotic therapy.
    Ji Y
    Pharmacogenomics; 2002 May; 3(3):315-23. PubMed ID: 12052140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using bacterial genomes and essential genes for the development of new antibiotics.
    Fields FR; Lee SW; McConnell MJ
    Biochem Pharmacol; 2017 Jun; 134():74-86. PubMed ID: 27940263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.